Agenda & Learning Objectives

Participants in this program will:

  • Explore progress towards precision health from a scientific and clinical perspective
  • Consider mechanisms of fibrosis from a scientific and clinical perspective
  • Integrate basic science and clinical practice by participating in a choice of workshops to:
    • Review the role of diet and pathobiomes in the microbiome
    • Develop strategies for antibiotic use in IBD
    • Consider the paradox of immunization and IBD
    • Examine complementary medicines and IBD
  • Examine pain mechanisms from a scientific and clinical perspective

NOTE: Junior Investigator Award – Please go to the Call for Abstracts page on the registration site

Time Title/Topic Speakers
8:30

0.1 Welcome 
Nurse of the Year Award, Physician of the Year Award, CCC-Pfizer Women in IBD Emerging Researcher Award, CCC-Pfizer Women in IBD Outstanding Researcher Award

 Lori Radke
CEO, Crohn's and Colitis Canada
8:40 0.2 Opening Remarks – Welcome, program objectives 
CO-CHAIRS:
Remo Panaccione & Hillary Steinhart
8:50 0.3 Overview of CCC 2023 Impact of IBD in Canada Report (15 mins) Eric Benchimol & Gilaad Kaplan

Session I: Precision Medicine
SESSION CHAIR:
Charles Bernstein
9:05 1.1 Plenary Presentation
Precision Medicine from the Basic to Translational Science Perspective
Bram Verstockt
9:25 1.2 Plenary Presentation
Precision Medicine in the IBD Clinic – Where are we today?
 James Lee
9:45 1.3 Ask-the Expert Panel Session MODERATOR: Charles Bernstein
PANEL: James Lee, Florian Rieder, Bram Verstockt
10:05
1.4 Junior Investigator Award & Presentation
 TBA
10:25 Refreshment Break (15 minutes)  

Session II: Mechanisms of Fibrosis 

 SESSION CHAIR: Laura Sly
10:40 2.1 Plenary Presentation
Fibrotic Pathways from the Basic to Translational Science Perspective
 Simon Hirota
 
11:00 2.2 Plenary Presentation
Clinical Approaches to the Management of Fibrosis
 Florian Rieder
11:20 2.3 Ask-the Expert Panel Session MODERATOR:: Laura Sly
PANEL: Simon Hirota, Klaus Kaestner, Florian Rieder
11:40 2.4 Rising Star Award & Presentation (title TBA) TBA
12:00 Lunch Break (60 minutes)  

Session III: Workshops – Hot Topics from Bench to Policy
13:00 Placement into Workshops  
13:00 3.1 Workshop
Microbiome: Diet and Resident Bacteria
 Deanna Gibson & Elena Verdu
3.2 Workshop
Antibiotics in IBD - The Good, the bad and the ugly
 Smita Halder & Laura Targownik
3.3 Workshop
Paradox of Immunization and IBD
 Eric Benchimol & Gilaad Kaplan
3.4 Workshop
Holistic Approaches to IBD Management
 Lesley Graff & Maitreyi Raman
13:50 Grab and Go Break (5 minutes)  

Session IV: Pain Mechanisms 

 SESSION CHAIR:
Andy Stadnyk
13:55 4.0 Research Leadership Award & Presentation TBA
14:15 4.1 Plenary Presentation
Pain Pathways from the Basic to Translational Science Perspective
 Keith Sharkey
14:35 4.2 Plenary Presentation
Treatment of Pain in the IBD Clinic
 Steve Vanner
 
14:55 4.3 Ask-the Expert Panel Session MODERATOR: Andy Stadnyk
PANEL: Yasmin Nasser, Keith Sharkey, Steve Vanner
15:15 Closing Remarks and Program Evaluation CO-CHAIRS: 
Remo Panaccione & Hillary Steinhart

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.